Susquehanna International Group’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $40.5K | Buy |
14,000
+800
| +6% | +$1.71K | ﹤0.01% | 12687 |
|
|
2025
Q4 | $21.3K | Sell |
13,200
-53,400
| -80% | -$84K | ﹤0.01% | 11944 |
|
|
2025
Q3 | $112K | Buy |
66,600
+45,500
| +216% | +$73.6K | ﹤0.01% | 11493 |
|
|
2025
Q2 | $25.5K | Sell |
21,100
-19,800
| -48% | -$28.7K | ﹤0.01% | 12279 |
|
|
2025
Q1 | $51.9K | Buy |
40,900
+10,000
| +32% | +$26.1K | ﹤0.01% | 11848 |
|
|
2024
Q4 | $100K | Sell |
30,900
-10,100
| -25% | -$36.4K | ﹤0.01% | 11345 |
|
|
2024
Q3 | $135K | Sell |
41,000
-12,300
| -23% | -$47.9K | ﹤0.01% | 10836 |
|
|
2024
Q2 | $227K | Buy |
53,300
+5,000
| +10% | +$48.7K | ﹤0.01% | 10074 |
|
|
2024
Q1 | $711K | Buy |
+48,300
| New | +$730K | ﹤0.01% | 7668 |
|
|
2023
Q3 | – | Sell |
-54,700
| Closed | -$293K | – | 12579 |
|
|
2023
Q2 | $293K | Sell |
54,700
-21,800
| -28% | -$134K | ﹤0.01% | 9489 |
|
|
2023
Q1 | $549K | Buy |
+76,500
| New | +$461K | ﹤0.01% | 8346 |
|
|
2022
Q1 | – | Sell |
-26,600
| Closed | -$427K | – | 13590 |
|
|
2021
Q4 | $427K | Sell |
26,600
-19,800
| -43% | -$373K | ﹤0.01% | 9583 |
|
|
2021
Q3 | $972K | Buy |
46,400
+3,200
| +7% | +$77.1K | ﹤0.01% | 7630 |
|
|
2021
Q2 | $1.16M | Sell |
43,200
-4,800
| -10% | -$141K | ﹤0.01% | 7347 |
|
|
2021
Q1 | $1.53M | Sell |
48,000
-13,600
| -22% | -$330K | ﹤0.01% | 6594 |
|
|
2020
Q4 | $1.41M | Buy |
61,600
+33,900
| +122% | +$780K | ﹤0.01% | 5877 |
|
|
2020
Q3 | $698K | Sell |
27,700
-26,200
| -49% | -$715K | ﹤0.01% | 6969 |
|
|
2020
Q2 | $1.5M | Buy |
53,900
+29,700
| +123% | +$516K | ﹤0.01% | 5026 |
|
|
2020
Q1 | $141K | Sell |
24,200
-13,100
| -35% | -$119K | ﹤0.01% | 9047 |
|
|
2019
Q4 | $406K | Sell |
37,300
-8,500
| -19% | -$84.1K | ﹤0.01% | 7394 |
|
|
2019
Q3 | $584K | Buy |
45,800
+13,400
| +41% | +$193K | ﹤0.01% | 6936 |
|
|
2019
Q2 | $550K | Sell |
32,400
-26,600
| -45% | -$457K | ﹤0.01% | 7081 |
|
|
2019
Q1 | $1.06M | Buy |
+59,000
| New | +$1.02M | ﹤0.01% | 4922 |
|
|
2018
Q4 | – | Sell |
-9,900
| Closed | -$212K | – | 9557 |
|
|
2018
Q3 | $212K | Buy |
+9,900
| New | +$211K | ﹤0.01% | 8111 |
|
|
2018
Q2 | – | Sell |
-12,000
| Closed | -$302K | – | 10072 |
|
|
2018
Q1 | $302K | Sell |
12,000
-27,500
| -70% | -$668K | ﹤0.01% | 7626 |
|
|
2017
Q4 | $751K | Buy |
39,500
+10,000
| +34% | +$187K | ﹤0.01% | 5816 |
|
|
2017
Q3 | $545K | Sell |
29,500
-2,300
| -7% | -$39.8K | ﹤0.01% | 6367 |
|
|
2017
Q2 | $557K | Buy |
31,800
+9,300
| +41% | +$177K | ﹤0.01% | 6442 |
|
|
2017
Q1 | $419K | Buy |
+22,500
| New | +$434K | ﹤0.01% | 6804 |
|
|
2016
Q4 | – | Sell |
-6,900
| Closed | -$206K | – | 9906 |
|
|
2016
Q3 | $206K | Buy |
+6,900
| New | +$205K | ﹤0.01% | 7540 |
|
|
2016
Q2 | – | Sell |
-10,200
| Closed | -$191K | – | 9028 |
|
|
2016
Q1 | $191K | Buy |
10,200
+2,800
| +38% | +$53.3K | ﹤0.01% | 8011 |
|
|
2015
Q4 | $229K | Buy |
+7,400
| New | +$225K | ﹤0.01% | 8204 |
|
Other funds holding MGNX
AC
VCM
RCM
WA
Susquehanna International Group's MGNX Position: Q1 2026 in Review
Susquehanna International Group increased its MacroGenics (MGNX) stake by 560% in Q1 2026, buying an estimated $818K and bringing the position to 452,227 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #7218.
Susquehanna International Group first reported a position in MGNX in Q4 2014 and has held it in 37 quarters since. The position peaked at $7.83M in Q1 2024. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.
- Susquehanna International Group held 452,227 shares of MacroGenics worth $1.31M as of Q1 2026.
- Susquehanna International Group bought 383,686 MacroGenics shares in Q1 2026, an estimated $818K.
- MacroGenics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7218 holding.
- Susquehanna International Group first reported a position in MacroGenics in Q4 2014 and has held it in 37 quarters since.
- Susquehanna International Group's MacroGenics position peaked at $7.83M in Q1 2024.
- 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.